Understanding the precise mechanisms of monogenic autoinflammatory diseases provides crucial insights into the complex pathophysiology of more common multifactorial diseases, while treatments ...

世界首例MALBAC-baby，10岁生日快乐！,baby,malbac,医学,遗传学 ...

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

Sensorion has announced the availability of its half-year 2024 report. Takeaway Points Sensorion Unveils Half-Year 2024 ...

Financially, Rhythm has $319.1 million in cash, but may need to raise more funds within the next 12 months. See why I rate ...

Its portfolio includes promising therapies for conditions like giant axonal neuropathy, Rett syndrome, and various forms of Batten disease. Taysha Gene Therapies works closely with The University of ...

Fulgent Genetics’ core revenue grew just 3% in H1 2024, with full-year guidance of $280 million. Learn more on FLGT stock ...

However, the cellular mechanisms by which MC4R regulates reproduction are unknown. Kiss1 neurons directly stimulate gonadotropin-releasing hormone (GnRH) release through two distinct populations; the ...

Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $68.86, a high estimate of $96.00, ...

GENinCode announced a collaboration with the Family Heart Foundation, UT Southwestern, and other partners on Friday, to ...

LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September ...